. 49:115-124, 1980) has been shown to contain two resistance loci which segregate independently on recombination with wild-type virus. One locus is in thymidine kinase, and the other is in DNA polymerase. Both induced enzymes have altered properties, thymidine kinase showing a low affinity for acyclovir and low activity, and DNA polymerase showing a low affinity for acyclovir triphosphate. Other properties of both enzymes are described which distinguish them from their wild-type counterparts. Recombinants containing either mutant thymidine kinase (RSC-11) or mutant DNA polymerase (RSC-26), but not both, have been used to investigate the relative contribution of each lesion to resistance and pathogenicity. Although SC16 RqC2 and both recombinants grow as well as does wild-type virus in tissue culture, they are considerably attenuated in vivo, the greatest attenuation of virulence being seen with SC16 R9C2 and RSC-26. With respect to both acyclovir resistance and in vivo growth, the lesions appear to behave synergistically. Cross resistance studies have shown the recombinant RSC-26, which contains mutant DNA polymerase but which evidently expresses wild-type thymidine kinase, to be cross resistant to both 5-iodo-2'-deoxyuridine and 5-trifluoromethyl-2'-deoxyuridine but not to (E)-5-(2-bromovinyl)-2'-deoxyuridine or 9-,B-D-arabinofuranosyladenine.
The acyclovir-resistant mutant SC16 R9C2 (H. J. Field, G. Darby, and P. Wildy, J. Gen. Virol. 49: [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] 1980 ) has been shown to contain two resistance loci which segregate independently on recombination with wild-type virus. One locus is in thymidine kinase, and the other is in DNA polymerase. Both induced enzymes have altered properties, thymidine kinase showing a low affinity for acyclovir and low activity, and DNA polymerase showing a low affinity for acyclovir triphosphate. Other properties of both enzymes are described which distinguish them from their wild-type counterparts. Recombinants containing either mutant thymidine kinase (RSC-11) or mutant DNA polymerase (RSC-26), but not both, have been used to investigate the relative contribution of each lesion to resistance and pathogenicity. Although SC16 RqC2 and both recombinants grow as well as does wild-type virus in tissue culture, they are considerably attenuated in vivo, the greatest attenuation of virulence being seen with SC16 R9C2 and RSC-26. With respect to both acyclovir resistance and in vivo growth, the lesions appear to behave synergistically. Cross resistance studies have shown the recombinant RSC-26, which contains mutant DNA polymerase but which evidently expresses wild-type thymidine kinase, to be cross resistant to both 5-iodo-2'-deoxyuridine and 5-trifluoromethyl-2'-deoxyuridine but not to (E)-5-(2-bromovinyl)-2'-deoxyuridine or 9-,B-D-arabinofuranosyladenine.
Herpes simplex virus (HSV) can acquire resistance to the nucleoside analog inhibitor acyclovir (ACV) (9-[(2-hydroxyethoxy)methyl]guanine) by mutation at either the thymidine kinase (TK) or the DNA polymerase locus (2, 12, 30) . Defects in TK result in failure to phosphorylate the drug (4, 16, 18) , and since it is the triphosphate of the analog which inhibits virus replication by its interaction with the viruscoded DNA polymerase (7, 17) , such lesions lead to drug resistance. The DNA polymerase itself may also undergo subtle changes which alter its substrate specificity and render it insensitive to inhibition by the analog triphosphate (6, 16) .
We have for some time been interested in the mechanisms by which HSV can acquire resistance to nucleoside analog inhibitors and the implications of a drug resistance phenotype for the pathogenicity of the virus (4, 11, 12, 25) . From our work and also observations made in several other laboratories, it has rapidly become clear that the most common mechanism leading to drug resistance in tissue culture is the acquisition of a phenotype characterized by little or no expression of TK (2, 12, 30, 31) and that this phenotype is associated with a marked lack of virulence (4, 11, 15, 29, 33, 34) .
Recently we described a class of TK mutants which express modified enzymes capable of phosphorylating thymidine but not ACV (4, 23, 25) . These viruses, which express TK levels greater than 30% of the wild-type (wt) level, show only slight attenuation of virulence in animal model systems (4, 14) .
A further class of mutants characterized by possessing a wt TK gene but having a lesion in DNA polymerase may possess considerable pathogenic potential (11, 22) . Few mutants of this type have been isolated after exposure of HSV to ACV. Exceptions are the mutants Cl(101) P2C5 isolated in this laboratory (12; unpublished data) and the mutant BWr described by Furman and his colleagues (16) . In addition to these two, there are several DNA polymerase mutants which are also defective in expression of TK, namely, Cl(101) TK-p7, SC16 R9C2 (12) , and ACGr4 (2, 16).
The virus SC16 RqC2 is of particular interest since it was recently shown to exhibit unusual pathogenicity when inoculated intracerebrally into mice at high doses (10) . (11, 12, 19) . To isolate recombinants of these viruses, BHK cells were infected with 5 PFU of each virus per cell, and progeny from the 24-h yield were cloned by plaque purification. Individual clones were assessed for their ability to induce TK, and their resistance to phosphonoacetic acid (PAA) was assessed by plaque reduction assay in BHK cells as described previously (12) .
All virus stocks were grown in BHK cells, using lowmultiplicity infection.
Extraction and purification of DNA polymerase and TK. The purification procedure employed was described previously (25) and allowed the isolation of both HSV DNA b ED50 values were determined by plaque reduction. Plaquing efficiency was plotted as a function of drug concentration, and the dose required to reduce the efficiency to 50% was read from the graph.
polymerase and TK from the same infected cell extract. Confluent monolayers of BU-BHK cells (about 2 x 108) were infected at a multiplicity of 10 PFU per cell. After infection for 18 h, the cells were harvested, pelleted, and frozen at -70TC until used. These pellets were then thawed and resuspended in 4 volumes of extraction buffer (250 mM potassium phosphate buffer [pH 7.5], 2 mM dithiothreitol [DTT], 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 50 ,uM thymidine, and 20% glycerol), and the cells were disrupted by ultrasonic vibration. All subsequent purification procedures were performed at 4°C. The sonicate was centrifuged at 15,000 rpm in a Sorvall RC-2B rotor for 30 min, and the supernatant was passed successively through two DEAE-cellulose columns. TK activity was recovered in the flow-through of the second column (at a concentration of 50 mM potassium phosphate buffer, pH 7.5), and HSV DNA polymerase activity was eluted with 250 mM potassium phosphate buffer, pH 7.5. HSV DNA polymerase was further purified through phospho-and DNA-cellulose columns, as described previously by Derse et al. (6) .
Fractions containing TK activity from the second DEAEcellulose column were pooled, and solid ammonium sulfate was added to 60% saturation. The precipitate formed was collected by centrifugation, dissolved in TK affinity column buffer A (0.05 M Tris-hydrochloride [pH 7.5], 2 mM DTT, and 10% glycerol), and applied to a thymidine-Sepharose affinity column equilibrated with buffer A. The chromatography procedure was similar to that employed previously (25) . The specific activities of the DNA polymerases and wt TKs were similar to those reported previously (25) , although the specific activities of TKs purified from SC16 R9C2-and RSC-11-infected cells were considerably lower than those obtained with the wt enzyme.
Enzyme assays. TK was assayed as described earlier (24, 25) (12, 13) . Antiviral drugs and other compounds. 5-Iodo-2'-deoxyuridine (IUdR), 5-trifluoromethyl-2'-deoxyuridine (TFT), and 9-,3-D-arabinofuranosyladenine (AraA) were induces only low levels of TK activity and is coresistant to PAA, a drug known to act at the level of DNA polymerase (20) . Our original interpretation was that there were lesions in both the TK gene and in DNA polymerase (12) . To confirm this, our first step was to demonstrate that the virus genome contained ACV resistance at two loci which segregated independently. The mutant was therefore crossed with wt virus (SC16) in a high-multiplicity infection, and recombia. resis, and separated on a 7.5 to 15% SDS-polyacrylamide gel.
Tracks: M, mock infected; A, virus SC16; B, mutant SC16 RqC2; C, recombinant RSC-26; and D, recombinant RSC-11. The TK polypeptides are indicated by the arrows and migrated slightly ahead of the actin band. The assignment of the TK polypeptide has been described previously (24) and was made by comparing the patterns generated by a TK-mutant (expressing no detectable TK polypeptide) and its wt parent. 1) .
Thus two resistance loci present in mutant SC16 R9C2 were segregated by recombination with wt virus, and evidence was now sought to confirm that the lesions were within the TK and DNA polymerase structural genes. Our approach was to investigate the properties of the enzymes induced by the parent and recombinant progeny.
Properties of TKs. Although kinetic studies on enzymes should ideally be performed on highly purified enzyme preparations, previous work had shown that reliable data on nucleoside substrate binding could be obtained with HSV TK by using high-speed supernatants from infected TKdeficient cells (23) (24) (25) . Since the levels of TK activity expressed by SC16 RqC2 and RSC-11 were low, and the enzymes were found to behave abnormally on thymidine affinity columns, making purification difficult, it was decided to use high-speed supernatants for their analysis.
Initially it was shown that the activities were destroyed by anti-HSV sera (data not shown), thus confirming that the enzymes were virus specified. Kinetic studies were then undertaken to determine the apparent binding affinities of the enzymes for various substrates. Data were obtained with radiolabeled thymidine as a substrate, and Km values were calculated trom Lineweaver-Burk plots (1 able 2). The results suggested similar binding affinities for thymidine with both mutant and wt enzymes. Ki values for ACV were then determined using ACV to inhibit thymidine phosphorylation (Fig. 1 ). There was a considerable reduction in the affinities of the mutant enzymes induced by SC16 RqC2 and RSC-11 for ACV (Ki values, 1.5 mM) when compared with the affinity of the wt enzyme for this analog (Ki value, 0.2 mM).
This reduction in affinity would probably be sufficient to preclude significant phosphorylation of ACV by this enzyme (25) .
In view of the apparently normal affinity of the mutant TK for thymidine, it was difficult to explain the low level of thymidine phosphorylation. Several possible explanations were considered. We could exclude the possibility that the TK polypeptide was underproduced as a result of a regulatory mutation (27) (Fig. 2) . Another explanation considered was that there might be a defect in ATP binding, such as that seen with TK induced by mutant SC16 S1 (23) . In fact, a small amount of purified enzyme was used to measure the Km for ATP, and the value obtained (70 p.M) was only threefold higher than that of the wt enzyme (Ki, 20 FM) ( Table 2 ). Finally we looked at the stability of the enzyme, since an unstable enzyme might also result in a decrease in the observed activity. The results (Fig. 3a) showed, however, that the mutant and wt TKs had similar stabilities at elevated temperatures.
Further evidence that the mutant TK induced by either mutant SC16 RqC2 or the recombinant was distinct from the wt was seen in the effect of changing salt concentrations on the activities of the enzymes (Fig. 3b) . Both mutant enzymes were inactivated by increasing salt concentrations, whereas the wt enzyme activity was enhanced at moderate concentrations, a result similar to that observed previously with the mutant SC16 S1(23).
The TK induced by the recombinant RSC-26 was in all these respects indistinguishable from the wt enzyme (Table 2 and Fig. 1, 2, and 3) , confirming that this recombinant possessed the wt TK gene.
Properties of DNA polymerases. The DNA polymerases induced by SC16, SC16 RqC2, and the recombinants derived from these viruses, RSC-11 and RSC-26, were purified, and similar specific activities to those reported previously (25) were obtained with all enzymes. The Km values for the natural substrates dGTP and dTTP and the Ki values for ACV-triphosphate and BVdU-triphosphate were determined ( Further evidence for the lack of inhibition of the mutant enzyme by ACV-and BVdU-triphosphates and by PAA was derived from direct inhibition studies on the polymerases induced by the four viruses (Fig. 4) . In fact, the polymerase induced by SC16 R9C2 and the recombinant RSC-26 appeared to be stimulated by low concentrations of ACV-triphosphate. Another feature which distinguished the polymerase induced by virus SC16 from those induced by SC16 RqC2 and RSC-26 was the response of the enzymes to increasing Mg2+ concentration (Fig. 5) . The wt enzyme showed maximum activity at ca. 2.5 mM MgCl2, whereas maximum activity with the other enzymes was at 5 mM MgCl2. This is similar to the data of Derse et al. (6) , who found that polymerases with lower affinities for phosphonoformic acid also had reduced affinities for Mg2+. The DNA polymerase induced by recombinant RSC-11 was indistinguishable from the wt enzyme in all experiments (Table 3 and Fig. 4 and 5) .
Growth characteristics. The growth characteristics of these viruses were investigated both in vitro in tissue culture cells and in vivo after inoculation into the mouse ear pinna. The growth curves of all four viruses in BHK cells were very similar (Fig. 6a) , and there was no suggestion that lesions in either SC16 RqC2 or the recombinants were affecting the rate of growth or the final yield. Similar results were obtained with the mouse L-cell line (data not shown).
The picture in the mouse ear was quite different (Fig. 6b  and c) . Whether assessed by direct titration of virus in the tissues or by the simpler, but less direct, device of measuring differences in thickness between infected and uninfected ears (28) as an indication of the extent of the inflammatory response, it was apparent that growth was affected by the lesions in the mutants. The wt virus reached high titers (105 PFU per ear) by days 3 to 5, but the double mutant SC16 RqC2 only attained titers of ca. 103 PFU per ear, 100-fold lower. The recombinants were intermediate in properties, with RSC-11 and RSC-26 reaching titers ca. 5-fold and 50-fold lower than the wt, respectively.
Thus, although growth of SC16 R9C2 is unimpaired in tissue culture, it grows very poorly in the tissues of mice. Surprisingly, both lesions in the mutant contribute to this failure, the mutation in DNA polymerase function apparently making a larger contribution than that of the lesion in TK.
The lack of viability of SC16 RqC2 and RSC-26 in mice could have been explained if the mutants exhibited a temperature sensitivity phenotype. However, we measured the reiative plaquing efficiency of RSC-26 at 39°C compared with 37°C, and it was higher (75%) than that observed with the wt virus (50%).
Pathogenicity studies. In view of the poor growth of recombirant RSC-26 in the mouse ear and the previously established lack of virulence of mutant SC16 RqC2 (10, 11) , we considered it worthwhile to investigate the neurovirulence of the recombinants. This was done by measuring the intracerebral LD50s in BALB/c mice. The results followed a similar pattern to those obtained in the mouse ear iti that the wt SC16 was most virulent (LD50, 7 PFU), RSC-11 was partially attenuated (LD50, 230 PFU), and RSC-26 showed greater attenuation (LD50, 1.6 x 103 PFU). However the attenuation of neither of these recombinants approached that observed previously (11) with mutant SC16 RqC2 (LD50, 105 PFU).
The result with RSC-11 provides added support for the idea proposed by Tenser et al. (34) that low levels of TK expression are important to the pathogenicity of the virus, in that this recombinant which expresses TK at 5% of the wt level is considerably more neurovirulent than bona fide TKmutants, which usually show LD50 values in the range from 105 to 106 PFU (4, 11) .
Cross resistance studies. Of considerable interest with drug-resistant variants is whether they exhibit cross resistance to other antiherpes drugs and whether any clear patterns emerge which might aid in the design of effective therapy. With these considerations in mind, we examined the sensitivity of this group of viruses to several clinically important antiherpes drugs (IUdR, TFT, AraA, ACV, BVdU, and PAA) ( Table 4 ).
The parent double-mutant SC16 RqC2 was cross resistant to all of the drugs tested except AraA. Not surprisingly, therefore, the recombinants were also sensitive to AraA. As anticipated, RSC-11 showed some resistance to all of those compounds whose mode of action involves activation by TK (i.e., IUdR, TFT, BVdU, and ACV), and as described already, it was sensitive to PAA, which acts exclusively on DNA polymerase. The recombinant RSC-26, which showed only slight resistance to ACV, showed cross resistance not only to PAA but also to the nucleoside analogs IUdR and TFT (when assessed in TK-cells). It was, however, sensitive to the other nucleoside analog tested, BVdU. This is consistent with the kinetic data obtained with purified polymerase, which suggested that the enzyme had only a threefold decrease in affinity for BVdU-triphosphate (Table 3) . 
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It is interesting that the lesions in mutant SC16 R9C2 appear to act synergistically with respect to resistance (see resistance indices, Table 4 ), the resistance of the parent being greater than that of either recombinant alone. If it is assumed that the level of sensitivity to ACV seen with a virus which fails to phosphorylate the drug is due to residual activation by cell enzymes generating low concentrations of ACV-triphosphate in the cell, then any reduction in the affinity of DNA polymerase for the analog triphosphate would be expected to result in a reduction in sensitivity. Consistent with this idea is the observation that a TK-virus passaged at high drug concentration may acquire enhanced resistance due to acquisition of a lesion in DNA polymerase (12) .
The TK induced by SC16 R9C2 (and by the recombinant RSC-11) is of interest since the activity observed in the infected cell is very low compared with that attained in a wtinfected cell. This is a phenomenon commonly observed among resistant mutants, but one largely ignored from the biochemical point of view (2, 12, 14, 30, 32) . Our results show in this case that the low level of activity observed is due to the synthesis of an altered enzyme. We can exclude the possibility of a defect in regulation (27) or occasional readthrough of an internal termination codon (3) since the TK polypeptide is synthesized in approximately normal quantities. The mutant enzyme has several properties which distinguish it from the wt, perhaps the most marked being its sensitivity to increased salt concentrations. This is a phenomenon observed previously with the TK substrate speci- R9C2 has lesions conferring resistance at two distinct genetic loci, since the markers can be segregated by recombination with the wt virus. Data on the enzymes induced by both SC16 RqC2 and the recombinants RSC-11 and RSC-26 have demonstrated lesions in both DNA polymerase and TK. We did not attempt precise measurement of the recombination frequency, but we know it must have been reasonably high since a relatively small number of clones isolated from the mixed infection with SC16 and SC16 RqC2 contained several viruses with phenotypes similar to that of either RSC-11 or RSC-26. (24) . Perhaps more relevant when considering the resistance of the virus to ACV is the reduced affinity of the mutant enzyme for the analog (Ki value, 1.5 mM compared with wt Ki value, 0.2 mM). The affinities of the enzyme for the natural substrates such as thymidine and ATP were not dramatically different from those of the wt enzyme, and the enzyme itself appeared relatively heat stable. The differences observed certainly would not explain the low activity observed, since the mutant SC16 Si which induces fivefold more TK activity (4) shows greater changes in all the above properties (23, 24) . The most likely explanation for the low activity observed would appear to be a mutation directly affecting the catalytic function of the enzyme, such that the conversion of the bound substrates (thymidine and ATP) to the products (dTMP and ADP) proceeds more slowly than with the wt enzyme. A further possibility which cannot be excluded at present is an impairment in the association of subunits leading to a reduction in the proportion of dimer (thought to be the active configuration) compared with monomer subunits.
The consequences tor the virus of losing 95% TK activity are most easily assessed by looking at the properties of the recombinant RSC-11, which expresses the mutant TK but apparently normal DNA polymerase. Since complete loss of TK function does not impair the ability of HSV type 1 to replicate in actively growing tissue culture cells (8, 15, 21) , it is not surprising that recombinant RSC-11 also replicates normally in tissue culture. This virus was clearly different from TK-strains in its behavior in mice, particularly with respect to its neurovirulence assessed by intracerebral inoculation. There was some attenuation (LD50, 230 PFU compared with 7 PFU for wt virus), but the recombinant was at least 100-fold more virulent than the TK-mutant SC16 R5C1 (LD50, 5 x 104 PFU) (11) derived from the same parent.
These results once more emphasize the importance of TK activity when virus is replicating in nerve tissues and support the contention of Tenser and his colleagues (34) that a low level of TK expression is of significant value to the virus in these tissues.
It is clear from the results that the lesion in TK is insufficient alone to explain the lack of virulence of the parent double mutant SC16 RqC2 (11) , and this raised the possibility that the lesion in DNA polymerase also contributes to this effect. Support for this contention was obtained by analysis of the in vivo properties of the recombinant RSC-26.
As with the TK lesion, the DNA polymerase lesion did not affect the ability of the virus to grow in culture, nor did it affect the temperature sensitivity of the virus. In view of this, it was expected that recombinant RSC-26 would be as virulent as the wt in mice. In practice this was not the case. Growth at the peripheral site in the ear was poor, and the LD50 assessed by intracerebral inoculation was at least 200-fold higher than in the wt. The reasons for this attenuation are not clear. One possibility is that there is a third lesion in SC16 RqC2 which affects pathogenicity and that this segregated with the DNA polymerase gene in RSC-26. At present we cannot exclude this possibility, although two other recombinants isolated which had TK+ PAAr phenotypes (like RSC-26) were both similarly attenuated with respect to neurovirulence.
The biochemical properties of the DNA polymerase induced by SC16 RqC2 explained the resistance of the virus to PAA and its enhanced resistance to ACV compared with other TK-deficient strains. The purified enzyme was resistant to inhibition by either PAA or ACV-triphosphate. Furthermore, binding studies indicated a 50-fold lower affinity of To confirm that the lesion in DNA polymerase contributed to the resistance of the virus, we examined the properties of the recombinant RSC-26. Although this virus expressed a polymerase identical in all respects to that of SC16 RqC2, it expressed wt TK. As expected, the resistance of RSC-26 to PAA was identical to that of SC16 R9C2. In contrast, its resistance to ACV was considerably lower, being only eightfold greater than that of wt (ED50 in BHK cells for RSC-26 was 1.4 ,uM ACV: ED50 for wt was 0.18 ,M), but this resistance was maintained in biochemically transformed cells.
It is interesting to note that, as with resistance to ACV in vitro, the effects of the two lesions on growth in vivo appear to be synergistic. Thus, SC16 R9C2 grows more poorly in tissues of the ear pinna and is considerably less neurovirulent than either recombinant virus. This may imply that the likelihood of such highly resistant strains becoming established in vivo is relatively low. Although it is clearly unwise to base too much hope on results obtained with one double mutant, some support for this contention can be seen in the reduced neurovirulence of the double mutant Cl(101) TKp7 when compared with Cl(101) TK-(the parent TK-virus) (11) .
Finally one of the most crucial questions concerning resistant viruses is whether they are likely to respond to other antiherpes drugs. We investigated this problem by looking at the resistance of SC16 RqC2 and the recombinants RSC-11 and RSC-26 to a series of clinically important compounds. The parent double-mutant was resistant to all except AraA (i.e., PAA, IUdR, BVdU, and TFT). The sensitivity to AraA was not too surprising since TK does not appear to be involved in the mode of action of this drug (18, 26) , and several other DNA polymerase mutants isolated with either PAA or phosphonoformic acid showed little cross resistance to AraA (2, 9) .
The recombinant RSC-11 showed a degree of cross resistance to those thymidine analogs requiring activation by phosphorylation (IUdR, BVdU, and TFT), results which were particularly marked in TK-cells. As expected, this recombinant was sensitive to PAA. This is the pattern expected of a TK-deficient virus (13) .
However, the recombinant RSC-26, which was PAA resistant but showed only marginal resistance to ACV, was resistant to the other nucleoside analogs IUdR and TFT (but not BVdU). This is a totally different pattern of cross resistance from the previously studied highly ACV-resistant DNA polymerase mutant Cl(101) P2C5, which was sensitive to PAA and all the nucleoside analogs tested (i.e., BVdU, IUdR, AraT, TFT, AraA, and bromodeoxyuridine) (13) . Thus, this work has indicated that it is possible to make some generalizations about likely patterns of pathogenicity and cross resistance of TK mutants but that it is clearly premature to attempt to do so with viruses whose lesions are in DNA polymerase, far more experience being required with mutants of this type.
Throughout this discussion, we have generally assumed that the only mutations affecting pathogenicity and drug resistance are those which lead to the modifications observed in the properties of the virus-specified DNA polymerase and TK. This assumption is likely to be valid when considering drug resistance, since no other virus-coded functions have been implicated so far in the modes of action of the drugs used in this study. However, the situation is less simple when we consider pathogenicity, since the products of many virus genes are likely to influence the behavior of the virus in its animal host. We cannot therefore exclude the possibility that some of the effects observed in animals were due to lesions outside the TK and DNA polymerase loci.
